These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25341887)

  • 21. Prognostic value of CT angiography in patients with inconclusive functional stress tests.
    de Azevedo CF; Hadlich MS; Bezerra SG; Petriz JL; Alves RR; de Souza O; Rati M; Albuquerque DC; Moll J
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):740-51. PubMed ID: 21757164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
    Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
    Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
    Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
    Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.
    Sörensen NA; Nikorowitsch J; Neumann JT; Rübsamen N; Goßling A; Hartikainen TS; Blankenberg S; Westermann D; Zeller T; Karakas M
    Clin Res Cardiol; 2019 Dec; 108(12):1386-1393. PubMed ID: 30989318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.
    Samman Tahhan A; Sandesara P; Hayek SS; Hammadah M; Alkhoder A; Kelli HM; Topel M; O'Neal WT; Ghasemzadeh N; Ko YA; Gafeer MM; Abdelhadi N; Choudhary F; Patel K; Beshiri A; Murtagh G; Kim J; Wilson P; Shaw L; Vaccarino V; Epstein SE; Sperling L; Quyyumi AA
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29467150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.
    Huang Y; Zhou H; Wu Y; Yang Y; Li W; Lu J; Hu Y
    Dis Markers; 2017; 2017():4719403. PubMed ID: 29109596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac and proinflammatory markers predict prognosis in cirrhosis.
    Wiese S; Mortensen C; Gøtze JP; Christensen E; Andersen O; Bendtsen F; Møller S
    Liver Int; 2014 Jul; 34(6):e19-30. PubMed ID: 24313898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study.
    Rasmussen LJ; Knudsen A; Katzenstein TL; Gerstoft J; Obel N; Jørgensen NR; Kronborg G; Benfield T; Kjaer A; Eugen-Olsen J; Lebech AM
    HIV Med; 2016 May; 17(5):350-7. PubMed ID: 26365671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.
    Hodges GW; Bang CN; Eugen-Olsen J; Olsen MH; Boman K; Ray S; Gohlke-Bärwolf C; Kesäniemi YA; Jeppesen JL; Wachtell K
    Can J Cardiol; 2016 Dec; 32(12):1462-1469. PubMed ID: 27499378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry.
    Al-Mallah MH; Qureshi W; Lin FY; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Chang HJ; Cademartiri F; Chinnaiyan K; Chow BJ; Cheng VY; Delago A; Gomez M; Hadamitzky M; Hausleiter J; Kaufmann PA; Leipsic J; Maffei E; Raff G; Shaw LJ; Villines TC; Cury RC; Feuchtner G; Plank F; Kim YJ; Dunning AM; Min JK
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):267-74. PubMed ID: 23966421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
    Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
    J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble urokinase-type plasminogen activator receptor represents exercise tolerance and predicts adverse cardiac events in patients with heart failure.
    Ishikawa H; Izumiya Y; Shibata A; Ichikawa Y; Yamaguchi T; Yamaguchi Y; Kitada R; Iwata S; Ehara S; Tomita S; Hanatani A; Yoshiyama M
    Heart Vessels; 2020 May; 35(5):681-688. PubMed ID: 31741050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.
    Ostrom MP; Gopal A; Ahmadi N; Nasir K; Yang E; Kakadiaris I; Flores F; Mao SS; Budoff MJ
    J Am Coll Cardiol; 2008 Oct; 52(16):1335-43. PubMed ID: 18929245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
    Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
    Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
    Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis.
    Li Y; Ding Y; Zhao Y; Gui Y; Shen Y; Xiang Q
    Eur J Clin Invest; 2022 Dec; 52(12):e13867. PubMed ID: 36039688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.
    Meyer J; Alstrup M; Rasmussen LJH; Schultz M; Ladelund S; Haupt TH; Tingleff J; Iversen K; Eugen-Olsen J
    Scand J Trauma Resusc Emerg Med; 2018 Feb; 26(1):11. PubMed ID: 29391054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.